Scutt_et_al_TADS_Supplementary_material – Supplemental material for Does the 5-HT1A rs6295 polymorphism influence the safety and efficacy of citalopram therapy in the oldest old?

Supplemental material, Scutt_et_al_TADS_Supplementary_material for Does the 5-HT1A rs6295 polymorphism influence the safety and efficacy of citalopram therapy in the oldest old? by Greg Scutt, Andrew Overall, Railton Scott, Bhavik Patel, Lamia Hachoumi, Mark Yeoman and Juliet Wright in Therapeutic Advances in Drug Safety